We are live on ! Find out more
GKIM

GW&K Investment Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 31.98%
This Fund
S&P 500
This Quarter Est. Return
+12.36%
1 Year Est. Return
+31.98%
3 Year Est. Return
+79.76%
5 Year Est. Return
+101.81%
10 Year Est. Return
+512.72%
AUM
$10.9B
AUM Growth
+$1.33B
Cap. Flow
+$448M
Cap. Flow %
4.12%
Top 10 Hldgs %
11.12%
Holding
401
New
25
Increased
172
Reduced
169
Closed
14

Sector Composition

Rank Sector Weight
1 Healthcare 16.95%
2 Consumer Discretionary 15.01%
3 Technology 14.98%
4 Industrials 14.53%
5 Financials 13.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
26
UnitedHealth
UNH
$361B
$80.2M 0.74%
215,527
+196
+0.1% +$67.9K
HUBS icon
27
HubSpot
HUBS
$11B
$77.7M 0.72%
171,137
-26,649
-13% -$11.7M
BJ icon
28
BJs Wholesale Club
BJ
$12B
$76.9M 0.71%
1,714,916
+412,393
+32% +$17.3M
AVGO icon
29
Broadcom
AVGO
$1.98T
$75.2M 0.69%
1,622,230
-16,190
-1% -$749K
MSFT icon
30
Microsoft
MSFT
$3.74T
$73.7M 0.68%
312,769
-3,448
-1% -$800K
SF
31
Stifel
SF
$12.7B
$73.4M 0.68%
1,717,787
-20,152
-1% -$785K
AVNT icon
32
Avient
AVNT
$4.17B
$72.7M 0.67%
1,539,015
+7,441
+0.5% +$332K
HZNP
33
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$72.1M 0.66%
783,371
+238,786
+44% +$20.2M
ABCB icon
34
Ameris Bancorp
ABCB
$5.92B
$71.5M 0.66%
1,361,483
-43,885
-3% -$2.09M
IR icon
35
Ingersoll Rand
IR
$33B
$70.3M 0.65%
1,427,868
+165,731
+13% +$7.67M
CTLT
36
DELISTED
CATALENT, INC.
CTLT
$69.9M 0.64%
663,347
+80,472
+14% +$8.98M
BIO icon
37
Bio-Rad Laboratories Class A
BIO
$9.53B
$67.5M 0.62%
118,123
+26,568
+29% +$15.7M
IT icon
38
Gartner
IT
$11.8B
$67M 0.62%
367,117
+95,152
+35% +$16.5M
AMT icon
39
American Tower
AMT
$79B
$66.3M 0.61%
277,146
+831
+0.3% +$185K
SKY icon
40
Champion Homes
SKY
$5.11B
$65.5M 0.6%
1,447,226
-331
-0% -$13.3K
DAVA icon
41
Endava
DAVA
$160M
$65.5M 0.6%
773,200
-1,225
-0.2% -$102K
TTC icon
42
Toro Company
TTC
$9.41B
$65.1M 0.6%
630,732
+73,861
+13% +$7.38M
PII icon
43
Polaris
PII
$3.99B
$64.9M 0.6%
486,259
+145,947
+43% +$17.8M
BIPC icon
44
Brookfield Infrastructure
BIPC
$4.92B
$63.6M 0.59%
1,248,944
-10,689
-0.8% -$482K
UFPI icon
45
UFP Industries
UFPI
$5.12B
$63.2M 0.58%
833,475
-7,604
-0.9% -$476K
EXPO icon
46
Exponent
EXPO
$3.25B
$63.1M 0.58%
647,467
-171,166
-21% -$16.1M
KWR icon
47
Quaker Houghton
KWR
$2.94B
$62.6M 0.58%
256,596
+25,008
+11% +$6.68M
EPAM icon
48
EPAM Systems
EPAM
$5.15B
$62.4M 0.57%
157,305
+20,668
+15% +$7.56M
AZTA icon
49
Azenta
AZTA
$1.46B
$62.4M 0.57%
764,030
+298,282
+64% +$24.1M
DOC
50
DELISTED
PHYSICIANS REALTY TRUST
DOC
$60.9M 0.56%
3,447,299
+234,353
+7% +$4.16M

Similar funds

GW&K Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, GW&K Investment Management held 401 positions worth $10.9B, up 14% from $9.53B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

GW&K Investment Management deployed $448M of net new capital in Q1 2021, opening 25 new positions and adding to 172 existing holdings. Its largest new stake was Diamondback Energy: 798,908 shares worth $58.7M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Haemonetics, an estimated $36.7M trimmed.

  • GW&K Investment Management's largest Q1 2021 buy was Diamondback Energy: 798,908 shares worth $58.7M.
  • GW&K Investment Management added most to Paylocity in Q1 2021, an estimated $43.4M increase.
  • GW&K Investment Management's biggest Q1 2021 reduction was Haemonetics, cutting an estimated $36.7M.
  • GW&K Investment Management fully exited PARSLEY ENERGY INC in Q1 2021, selling an estimated $38.5M.
  • GW&K Investment Management's ten largest holdings make up 11% of its $10.9B portfolio in Q1 2021.
  • GW&K Investment Management opened 25 new positions and closed 14 in Q1 2021.
  • GW&K Investment Management's portfolio value rose 14% quarter-over-quarter to $10.9B.

Based on GW&K Investment Management's 13F filing for Q1 2021, filed 11 May 2021.